Abstract
In the U.S., most bleeding peptic ulcers result from the use of nonsteroidal anti-inflammatory drugs (NSAIDs). Risk for gastrointestinal lesions is well established for prescription-strength NSAIDs but not for lower doses that are available over-the-counter (OTC). To estimate the risk for gastrointestinal toxicity with low-dose OTC NSAIDs, investigators, with industry funding, performed a retrospective case-control study. A total of 359 patients who …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
